Dr. Robert S. Langer Jr., also known as Bob, Jr., Ph.D., Sc.D., is a Co-Founder and Principal of Combinent Biomedical Systems, Inc. Dr. Langer is a Co-founder of Seventh Sense Biosystems, Inc. Dr. Langer is a Co-founder and Scientific Advisor at Gecko Biomedical SAS. He is Founder of XTuit Pharmaceuticals, Inc. He is a Co-Founder of PureTech Health plc. He serves as Medical, Science and Technology Adviser at 3-D Matrix, Ltd. He is the Founder of SQZ Biotechnologies Company. Dr. Langer is a Co-Founder of PixarBio Corporation. Dr. Langer is a Co-Founder of 480 Biomedical, Inc. and Tarveda Therapeutics, Inc. (also known as Blend Therapeutics, Inc.). He is a Co-Founder and Scientific Advisor of LiRIS Biomedical, Inc. He co-founded T2 Biosystems, Inc. in 2006. He serves as Scientific Advisor of Accurexa, Inc., TremRx Inc., and Algenol Biofuels Inc. He is a Co-Founder of Alnylam and Advanced Inhalation Research, Inc. He is a Co-founder of TARIS BioMedical, Inc. and served as its Scientific Advisor. He co-founded Microchips Biotech, Inc. in 1999 and Semprus BioSciences Corp. in 2007. He has helped launch 25 companies. He served as the Chief Scientific Advisor of Fibrocell Science, Inc. He was a Co-Founder of Momenta Pharmaceuticals Inc. He served as a Consultant at BIND Therapeutics, Inc. (now DNIB Unwind, Inc.). He was a Senior Partner of PureTech Health plc. Dr. Langer co-founded Living Proof, Inc. in 2005. He served as a Consultant at Fibrocell Science, Inc. since September 2009 and Sontra Medical Inc. since 1998. He was Founder of Parallel Solutions, Inc. He founded Pulmatrix, Inc. in 2003. He co-founded DNIB in 2006, Pervasis Therapeutics, Inc. in 2003 and Selecta Biosciences, Inc. in 2007. He was a Founder at ModeRNA Therapeutics Inc. He was a Co-Founder of Echo Therapeutics, Inc. He co-founded Arsenal Medical, Inc. in 2005 and Transform Pharmaceuticals Inc. in 1999. He served as a Scientific Consultant of Echo Therapeutics, Inc. since June 2002. His research interest includes drug delivery, biotechnology, immobilized enzymes and biomedical engineering. He co-founded InVivo Therapeutics Holdings Corp. in 2005. Dr. Langer serves as the Chairman of Scientific Advisory Board of AeroDesigns, Inc. He serves as the Chairman of Clinical Advisory Board at 3-D Matrix, Inc. He serves as the Chairman of Scientific Advisory Board at Quantum Designs, LLC. He has been the Chairman of the Scientific Advisory Board at Ocata Therapeutics, Inc. since September 2014. He serves as the Chairman of Scientific Advisory Board of Semprus BioSciences Corp. Dr. Langer serves as the Chairman of Scientific Advisory Board at Micell Technologies, Inc. He serves as Chairman of Advisory Board of Perosphere Inc. He has been Chairman of the Scientific Advisory Board at Advanced Cell Technology Inc since 9, 2014. He served as Chairman of Scientific Advisory Board of Pulmatrix, Inc. and serves as its Member of Scientific Advisory Board. He serves as a Non-Executive Director at PureTech Health plc. He serves as a Director at CropX Ltd. He serves as a Director at StemBioSys, Inc. He has been a Director of Advanced Cell Technology Inc since October 2011. He serves as a Director of Entrega. He serves as a Director of Rubius Therapeutics, Inc. and SQZ Biotechnologies Company. He serves as a Director at LiRIS Biomedical, Inc., Microchips Biotech, Inc., Living Proof, Inc., McGovern Institute, Fort Dodge Animal Health, S.p.A., Combinent Biomedical Systems, Inc., EGWU, Inc., Semprus BioSciences Corp., Humacyte, Inc., Seventh Sense Biosystems, Inc., Micell Technologies, Inc., PureTech Ventures, 480 Biomedical, Inc., Arsenal Medical, Inc., Kala Pharmaceuticals, Inc., Boston Life Sciences, Inc., Pervasis Therapeutics Inc., and Taris Biomedical, Inc. He serves as a Director and Member of Scientific Advisory Board at Tarveda Therapeutics, Inc. He serves as a Director and Member of Scientific Advisory Board of Moderna Therapeutics, Inc. He has been Director and Member of Scientific Advisory Board at CHS Pharma since July 12, 2013. He serves as a Member of Scientific Advisory Board at Agenovir Corporation. He serves as a Member of Scientific Advisory Board at Pulmatrix. He serves as a Member of Scientific Advisory Board at Abpro Corporation. He has been a Member of Scientific Advisory Board at Kalytera Therapeutics, Inc. since June 23, 2016. He serves as a Member of Advisory Board at Perosphere Inc. He is a Member of Scientific Advisory Board of eLux Medical, Inc. since August 2014 and Portal Instruments, Inc. since May 1, 2015. He serves as a Member of Strategic Advisory Board at HealthCare Royalty Partners. He serves as a Member of Editorial Advisory Board at Xconomy, Inc. He serves as a Member of Scientific Advisory Board at InVivo Therapeutics Holdings Corp., KensaGroup, LLC, Insert Therapeutics, Inc., (now Calando Pharmaceuticals, Inc.), VGX Pharmaceuticals, LLC, Respira Therapeutics, Inc., Juniper Pharmaceuticals, Inc., and Asterand Bioscience, Inc. He serves as a Member of Scientific Advisory Board of mNemoscience GmbH, Soft Tissue Regeneration, Inc., Calando Pharmaceuticals, Inc., CSP Technologies, Inc. He has been a Director of Kala Pharmaceuticals, Inc., since December 2009. He has been a Member of Scientific Advisory Board of Alnylam Pharmaceuticals, Inc. since June 2010. He serves as a Member of Scientific and Clinical Advisory Board at Civitas Therapeutics, Inc. Dr. Langer serves as Advisory Board Member of ATEM Capital. He serves as a Member of Advisory Board at Mosaic Biosciences, Inc., Performance Indicator, LLC and Polaris Partners, Inc., and Member of Scientific Advisory Board at Fate Therapeutics, Inc. He serves as a Member of Advisory Board at Cerulean Pharma Inc. and Nanobiosym, Inc. Dr. Langer focuses on helping Nanobiosym customize its nanotechnology platforms for companion diagnostic applications that accelerate the discovery, clinical validation and FDA approvals of novel pharmaceuticals. He also advises Nanobiosym Diagnostics on its global healthcare portfolio. He serves as a Member of Scientific Advisory Board at SiO2 Medical Products, Inc. and ADViSYS, Inc. He has been a Member of Scientific Advisory Board at PureTech Health PLC since November 30, 2015. He served as a Director at Selecta Biosciences, Inc. since 2007 until June 2016. He served as a Director at GMP Companies and Alkermes plc. He served as Director at Wyeth LLC since January 12, 2004. He served as a Director of DNIB since 2006. He served as a Director of Sontra Medical Inc. since 1998 and EMD Millipore Corporation from December 2009 to July 2010. He served as a Director of Echo Therapeutics, Inc. from June 2002 to December 30, 2009. He served as a Director of Soft Tissue Regeneration, Inc. He served as a Director of T2 Biosystems, Inc., from 2006 to August 2014. He served as an Independent Director of Fibrocell Science, Inc. from September 2009 to October 2012 and also served as its Member of Scientific Advisory Board. 

 Bio Sciences